Metagenomi Therapeutics (MGX) Asset Utilization Ratio (2024 - 2026)
Metagenomi Therapeutics (MGX) posted quarterly Asset Utilization Ratio of 0.11 for Q1 2026, down 26.54% year-over-year from 0.15 in Q1 2025, and down 0.62% quarter-over-quarter from 0.11 in Q4 2025.
Metagenomi Therapeutics (MGX) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has reported Asset Utilization Ratio for 3 consecutive years, with 0.11 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 26.54% year-over-year to 0.11; the TTM figure through Mar 2026 stood at 0.11 (down 26.54% YoY), while the FY2025 annual figure was 0.09, down 39.09% from the prior year.
- Asset Utilization Ratio declined to 0.11 in Q1 2026 per MGX's latest filing, from 0.11 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.15 in Q4 2024 and bottomed at 0.11 in Q1 2026.
- Historically, Asset Utilization Ratio has averaged 0.13 across 3 years, with a median of 0.12 in 2024.
- On a YoY basis, Asset Utilization Ratio climbed as much as 20.06% in 2025 and fell as far as 29.81% in 2025.
- Metagenomi Therapeutics' Asset Utilization Ratio stood at 0.15 in 2024, then retreated by 29.81% to 0.11 in 2025, then declined by 0.62% to 0.11 in 2026.
- Business Quant data shows MGX's Asset Utilization Ratio at 0.11 in Q1 2026, 0.11 in Q4 2025, and 0.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | 0.13 |
| 10 | Metagenomi Therapeutics | 47.14 Mn | 47.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.11 |
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | 0.15 |
| Sep 30, 2024 | 0.15 |
| Jun 30, 2024 | 0.14 |
| Mar 31, 2024 | 0.12 |